lu af11167
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2013 (NCT02202213)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lu af11167
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04104503 | Phase 1 | Sep 17, 2019 | Lundbeck |
| NCT03929497 | Phase 2 | Apr 22, 2019 | Lundbeck |
| NCT03793712 | Phase 2 | Dec 27, 2018 | Lundbeck |
| NCT02260830 | Phase 1 | Aug 1, 2014 | Lundbeck |
| NCT02199431 | Phase 1 | Jul 1, 2014 | Lundbeck |
| NCT02202213 | Phase 1 | Oct 1, 2013 | Lundbeck |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lundbeck | For profit | 6 | 6 | 2 | 2013 |
1 organizations
Page 1 / 1